Caroline M Mitchell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagina | 30 | 2023 | 825 | 7.590 |
Why?
|
Vaginal Diseases | 13 | 2023 | 102 | 5.400 |
Why?
|
Vaginosis, Bacterial | 12 | 2022 | 128 | 4.270 |
Why?
|
Postmenopause | 17 | 2022 | 2458 | 4.060 |
Why?
|
Estradiol | 11 | 2022 | 2017 | 2.700 |
Why?
|
Lactobacillus | 11 | 2023 | 189 | 2.070 |
Why?
|
Menopause | 10 | 2023 | 1626 | 1.930 |
Why?
|
Vaginal Creams, Foams, and Jellies | 6 | 2022 | 63 | 1.920 |
Why?
|
Estrogens | 9 | 2022 | 1563 | 1.720 |
Why?
|
Female Urogenital Diseases | 2 | 2021 | 52 | 1.390 |
Why?
|
RNA, Ribosomal, 16S | 7 | 2023 | 954 | 1.300 |
Why?
|
Lasers, Gas | 2 | 2020 | 93 | 1.240 |
Why?
|
Vulvar Diseases | 4 | 2019 | 61 | 1.020 |
Why?
|
Estrone | 3 | 2022 | 240 | 1.000 |
Why?
|
Cervix Uteri | 2 | 2021 | 590 | 0.970 |
Why?
|
Vaginal Douching | 2 | 2021 | 14 | 0.920 |
Why?
|
Vaginal Discharge | 2 | 2021 | 25 | 0.880 |
Why?
|
Dyspareunia | 3 | 2019 | 50 | 0.870 |
Why?
|
Vulva | 2 | 2023 | 87 | 0.850 |
Why?
|
Vaginitis | 1 | 2021 | 47 | 0.800 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2021 | 94 | 0.780 |
Why?
|
Estrogen Replacement Therapy | 4 | 2022 | 1203 | 0.740 |
Why?
|
Bacteroides | 1 | 2020 | 161 | 0.740 |
Why?
|
Mucus | 1 | 2021 | 321 | 0.700 |
Why?
|
Sexual Dysfunctions, Psychological | 3 | 2022 | 182 | 0.700 |
Why?
|
Epithelium | 2 | 2021 | 1679 | 0.660 |
Why?
|
Urinary Incontinence | 1 | 2023 | 496 | 0.660 |
Why?
|
Premenopause | 2 | 2021 | 1033 | 0.640 |
Why?
|
Administration, Intravaginal | 5 | 2021 | 150 | 0.640 |
Why?
|
Cytokines | 3 | 2021 | 7324 | 0.590 |
Why?
|
Genital Diseases, Female | 1 | 2018 | 197 | 0.590 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2428 | 0.570 |
Why?
|
Vulvovaginitis | 1 | 2016 | 16 | 0.550 |
Why?
|
Sexually Transmitted Diseases | 1 | 2021 | 623 | 0.520 |
Why?
|
Atrophy | 4 | 2023 | 1577 | 0.520 |
Why?
|
Metronidazole | 4 | 2022 | 217 | 0.460 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.460 |
Why?
|
Female | 56 | 2023 | 380020 | 0.460 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2014 | 163 | 0.450 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 255 | 0.430 |
Why?
|
Interleukin-8 | 2 | 2021 | 690 | 0.420 |
Why?
|
Endometrium | 1 | 2014 | 423 | 0.410 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1911 | 0.400 |
Why?
|
Sexual Behavior | 4 | 2022 | 2049 | 0.390 |
Why?
|
Carrier State | 1 | 2014 | 518 | 0.380 |
Why?
|
Premature Birth | 3 | 2021 | 1722 | 0.360 |
Why?
|
Glycogen | 3 | 2023 | 259 | 0.350 |
Why?
|
Escherichia coli | 1 | 2021 | 4216 | 0.340 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2134 | 0.340 |
Why?
|
Women's Health | 2 | 2018 | 2033 | 0.340 |
Why?
|
HIV-1 | 3 | 2016 | 6939 | 0.320 |
Why?
|
Humans | 56 | 2023 | 743811 | 0.310 |
Why?
|
HIV Seronegativity | 1 | 2008 | 211 | 0.290 |
Why?
|
Bacteria | 5 | 2023 | 2112 | 0.290 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2021 | 2556 | 0.280 |
Why?
|
Gardnerella vaginalis | 3 | 2014 | 13 | 0.270 |
Why?
|
Hot Flashes | 3 | 2020 | 316 | 0.260 |
Why?
|
Middle Aged | 21 | 2023 | 213241 | 0.260 |
Why?
|
Interleukin-6 | 2 | 2021 | 3208 | 0.260 |
Why?
|
Inflammation | 3 | 2021 | 10629 | 0.250 |
Why?
|
Metabolome | 2 | 2022 | 894 | 0.250 |
Why?
|
Amylases | 1 | 2023 | 173 | 0.230 |
Why?
|
Double-Blind Method | 5 | 2022 | 12020 | 0.230 |
Why?
|
Syndrome | 2 | 2020 | 3249 | 0.220 |
Why?
|
Interleukin-1beta | 1 | 2008 | 973 | 0.210 |
Why?
|
Tablets | 1 | 2022 | 145 | 0.210 |
Why?
|
HIV Infections | 4 | 2021 | 16715 | 0.210 |
Why?
|
Acetic Acid | 1 | 2021 | 55 | 0.210 |
Why?
|
Mycoplasma genitalium | 1 | 2021 | 10 | 0.200 |
Why?
|
Sodium Bicarbonate | 1 | 2021 | 63 | 0.200 |
Why?
|
Glycerol | 1 | 2022 | 278 | 0.200 |
Why?
|
Mycoplasma Infections | 1 | 2021 | 118 | 0.200 |
Why?
|
Minnesota | 1 | 2021 | 344 | 0.190 |
Why?
|
Microbial Interactions | 1 | 2021 | 76 | 0.190 |
Why?
|
Aging | 2 | 2019 | 8655 | 0.190 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7172 | 0.180 |
Why?
|
Chlamydia trachomatis | 1 | 2021 | 246 | 0.180 |
Why?
|
Iodine | 1 | 2021 | 286 | 0.170 |
Why?
|
Personality | 1 | 2023 | 552 | 0.170 |
Why?
|
Neisseria gonorrhoeae | 1 | 2021 | 238 | 0.160 |
Why?
|
Quality of Life | 5 | 2020 | 12788 | 0.160 |
Why?
|
Estriol | 1 | 2018 | 53 | 0.160 |
Why?
|
Mucins | 1 | 2021 | 564 | 0.160 |
Why?
|
Pregnancy | 10 | 2023 | 29140 | 0.150 |
Why?
|
Coculture Techniques | 1 | 2021 | 1342 | 0.150 |
Why?
|
Chlamydia Infections | 1 | 2021 | 365 | 0.150 |
Why?
|
Gynecology | 1 | 2023 | 512 | 0.150 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2009 | 2027 | 0.150 |
Why?
|
Aged | 10 | 2023 | 163178 | 0.150 |
Why?
|
Gonorrhea | 1 | 2021 | 335 | 0.150 |
Why?
|
Gels | 1 | 2018 | 425 | 0.140 |
Why?
|
Obstetrics | 1 | 2023 | 657 | 0.140 |
Why?
|
Immune System | 1 | 2021 | 807 | 0.140 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2019 | 281 | 0.140 |
Why?
|
Cesarean Section | 2 | 2023 | 1365 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1870 | 0.130 |
Why?
|
Young Adult | 7 | 2021 | 56392 | 0.130 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 238 | 0.130 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 788 | 0.130 |
Why?
|
Megasphaera | 1 | 2014 | 2 | 0.130 |
Why?
|
Leptotrichia | 1 | 2014 | 12 | 0.130 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13980 | 0.130 |
Why?
|
Prevotella | 1 | 2014 | 79 | 0.130 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2018 | 503 | 0.130 |
Why?
|
Placebo Effect | 1 | 2018 | 503 | 0.120 |
Why?
|
Actinobacteria | 1 | 2014 | 56 | 0.120 |
Why?
|
Adult | 13 | 2021 | 213889 | 0.120 |
Why?
|
Molecular Typing | 1 | 2014 | 106 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9944 | 0.120 |
Why?
|
Cyclohexanols | 1 | 2014 | 127 | 0.120 |
Why?
|
Adolescent | 8 | 2019 | 85729 | 0.120 |
Why?
|
Uterine Diseases | 1 | 2014 | 135 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 906 | 0.110 |
Why?
|
Drug Implants | 1 | 2014 | 241 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2021 | 63042 | 0.110 |
Why?
|
Immunity, Mucosal | 1 | 2016 | 490 | 0.110 |
Why?
|
Metabolomics | 1 | 2021 | 1487 | 0.110 |
Why?
|
Patient Preference | 1 | 2019 | 889 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15526 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2009 | 0.100 |
Why?
|
Cell Survival | 1 | 2021 | 5881 | 0.100 |
Why?
|
Prevalence | 3 | 2019 | 15211 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2016 | 847 | 0.090 |
Why?
|
Affect | 1 | 2018 | 1473 | 0.090 |
Why?
|
Mucous Membrane | 1 | 2014 | 669 | 0.090 |
Why?
|
Self Report | 2 | 2019 | 3550 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1121 | 0.090 |
Why?
|
Risk | 1 | 2021 | 9677 | 0.090 |
Why?
|
Hysterectomy | 1 | 2014 | 927 | 0.080 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2008 | 23 | 0.080 |
Why?
|
Pregnancy in Adolescence | 1 | 2010 | 158 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 331 | 0.080 |
Why?
|
Cohort Studies | 4 | 2019 | 40545 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3492 | 0.080 |
Why?
|
Clothing | 1 | 2007 | 95 | 0.070 |
Why?
|
Menstrual Cycle | 1 | 2010 | 551 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 25032 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8660 | 0.070 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2020 | 355 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1523 | 0.070 |
Why?
|
Infant | 3 | 2023 | 35122 | 0.070 |
Why?
|
Cultural Characteristics | 1 | 2007 | 261 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 5983 | 0.060 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2022 | 54 | 0.050 |
Why?
|
Prenatal Care | 1 | 2010 | 1092 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6170 | 0.050 |
Why?
|
Vacuum Curettage | 1 | 2002 | 48 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57744 | 0.050 |
Why?
|
Mothers | 2 | 2023 | 2166 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 21733 | 0.050 |
Why?
|
Administration, Oral | 1 | 2009 | 3912 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3874 | 0.050 |
Why?
|
Communication Barriers | 1 | 2023 | 398 | 0.050 |
Why?
|
Time Factors | 2 | 2018 | 40038 | 0.040 |
Why?
|
Regression Analysis | 1 | 2008 | 6457 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 972 | 0.040 |
Why?
|
Attitude to Health | 1 | 2007 | 2052 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 871 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2007 | 1342 | 0.040 |
Why?
|
Feces | 1 | 2022 | 1397 | 0.040 |
Why?
|
Abortion, Induced | 1 | 2002 | 458 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 474 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3921 | 0.030 |
Why?
|
Body Image | 1 | 2019 | 610 | 0.030 |
Why?
|
Orgasm | 1 | 2014 | 61 | 0.030 |
Why?
|
Breast Feeding | 1 | 2022 | 1338 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 77410 | 0.030 |
Why?
|
Probiotics | 1 | 2018 | 350 | 0.030 |
Why?
|
Self Concept | 1 | 2019 | 1024 | 0.030 |
Why?
|
Perimenopause | 1 | 2014 | 139 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2954 | 0.030 |
Why?
|
Inpatients | 1 | 2023 | 2515 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1004 | 0.020 |
Why?
|
Prospective Studies | 3 | 2014 | 53250 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2419 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 72252 | 0.020 |
Why?
|
Gestational Age | 2 | 2010 | 3488 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2656 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2009 | 290 | 0.020 |
Why?
|
Africa, Eastern | 1 | 2007 | 71 | 0.020 |
Why?
|
Washington | 1 | 2007 | 314 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2505 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6188 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2971 | 0.020 |
Why?
|
Anxiety | 1 | 2018 | 4288 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2007 | 402 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2009 | 1463 | 0.010 |
Why?
|
Logistic Models | 2 | 2010 | 13404 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39001 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7270 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2010 | 1151 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25609 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3503 | 0.010 |
Why?
|
Health Education | 1 | 2007 | 1056 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2794 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2683 | 0.010 |
Why?
|
Depression | 1 | 2018 | 7760 | 0.010 |
Why?
|
Pregnancy Trimester, First | 1 | 2002 | 853 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8337 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9848 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3020 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12243 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4031 | 0.010 |
Why?
|
Vitamin D | 1 | 2007 | 3222 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20948 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23327 | 0.010 |
Why?
|
Male | 1 | 2022 | 349776 | 0.000 |
Why?
|